IPP Bureau
Eight Roads Ventures to host fourth edition of Scale-Up Health conference on Sept 10
By IPP Bureau - August 14, 2025
The conference will explore the path to India’s first billion-dollar drug, evolution towards value-based healthcare, biotech breakthroughs, and the role of AI and LLMs in care delivery
Indoco Remedies receives final USFDA approval for rivaroxaban tablets
By IPP Bureau - August 13, 2025
Rivaroxaban is used to treat venous thromboembolism
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
By IPP Bureau - August 13, 2025
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Apollo Hospitals Q1 FY26 PAT up 42% to Rs. 433 Cr
By IPP Bureau - August 13, 2025
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Marksans Pharma reports Q1 FY26 gross profit 8.9% higher at Rs. 358.2 Cr
By IPP Bureau - August 13, 2025
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Granules India Q1 FY26 PAT slips to Rs. 112.6 Cr
By IPP Bureau - August 13, 2025
Zydus Lifesciences reports Q1 FY26 net profit at Rs. 1,466.8 Cr
By IPP Bureau - August 13, 2025
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Pfizer launches 20-valent Pneumococcal Conjugate Vaccine for adults in India
By IPP Bureau - August 12, 2025
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
.jpg "Briefs: Nectar Lifesciences, Cipla and Marksans Pharma")
Briefs: Nectar Lifesciences, Cipla and Marksans Pharma
By IPP Bureau - August 12, 2025
Marksans Pharma gets USFDA nod for acid reflux drug
Glenmark Pharmaceuticals reached $37.75 million settlement in antitrust litigation in US
By IPP Bureau - August 12, 2025
Glenmark USA is named in multiple antitrust and consumer protection lawsuits, including class actions, consolidated in the Eastern District of Pennsylvania, U.S
Centrient Pharmaceuticals joins UNGC
By IPP Bureau - August 12, 2025
Reinforcing commitment to ethical and sustainable growth
Sartorius and Nanotein Technologies partner to advance cell therapy manufacturing
By IPP Bureau - August 12, 2025
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Asian Institute of Nephrology & Urology expands hospital in Banjara Hills, Hyderabad
By IPP Bureau - August 12, 2025
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Sandoz launches renewable energy partnership
By IPP Bureau - August 12, 2025
The agreement complements other PPAs for Sandoz production sites globally
Boehringer’s lung cancer medicine gets FDA approval
By IPP Bureau - August 12, 2025
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
